Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported SER revenue for 2026-06-30 was $0. Net income was -$13.3M. SER currently screens at market cap $29.7M.
Use this SER page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SER quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SER SEC filings page. Lician reads the product cache first so this HTML stays unique to Serina Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SER income, balance, and cash tables.